Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Schnider

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Journal of Neurology|July 26, 2002
The impact of blepharospasm and cervical dystonia on health-related quality of life and depressionJ Müller, G Kemmler, J Wissel, et al.
British Journal of Pharmacology|November 3, 2010
Characterization of RO4583298 as a novel potent, dual antagonist with in vivo activity at tachykinin NK₁ and NK₃ receptorsP Malherbe, F Knoflach, M C Hernandez, et al.
Journal of Neurology|May 16, 2002
Efficacy and safety of a standardised 500 unit dose of Dysport (clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-controlled, parallel group studyJ Wissel, P Kanovsky, E Ruzicka, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Journal of Neurology|July 26, 2002
The impact of blepharospasm and cervical dystonia on health-related quality of life and depressionJ Müller, G Kemmler, J Wissel, et al.
British Journal of Pharmacology|November 3, 2010
Characterization of RO4583298 as a novel potent, dual antagonist with in vivo activity at tachykinin NK₁ and NK₃ receptorsP Malherbe, F Knoflach, M C Hernandez, et al.
Journal of Neurology|May 16, 2002
Efficacy and safety of a standardised 500 unit dose of Dysport (clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-controlled, parallel group studyJ Wissel, P Kanovsky, E Ruzicka, et al.
Pageof 7